Needle Biopsy Market Size, Share, Trends, Growth, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Table of Content

1. Preface

    1.1. Market  Definition and Scope

    1.2. Market  Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Needle Biopsy Market

4. Market  Overview

    4.1. Introduction

        4.1.1. Market  Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market  Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Needle Biopsy Market Analysis and Forecast, 2018–2030

        4.4.1. Market  Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections

5. Key Insights

    5.1. Disease Prevalence & Incidence Rate globally with key countries

    5.2. Overview of the Image Guided Needle Biopsy

    5.3. Regulatory Scenario by Region/globally

    5.4. COVID-19 Pandemics Impact on Global Needle Biopsy Market

6. Global Needle Biopsy Market Analysis and Forecast, by Type   

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Needle Biopsy Market Value & Volume Forecast, by Type, 2018–2030

        6.3.1. Fine-Needle Aspiration Biopsy

        6.3.2. Core Needle Biopsy

    6.4. Market Attractiveness Analysis, by Type

7.   Global Needle Biopsy Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Needle Biopsy Market Value Forecast, by Application, 2018–2030

        7.3.1. Breast Cancer

        7.3.2. Thyroid Cancer

        7.3.3. Prostate Cancer

            7.3.3.1. Transperineal

            7.3.3.2. Transrectal

        7.3.4. Liver Cancer

        7.3.5. Others

    7.4. Market  Attractiveness Analysis, by Application

8. Global Needle Biopsy Market Analysis and Forecast, by End-user  

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        8.3.1. Hospitals

        8.3.2. Diagnostics and Imaging Centers

        8.3.3. Research Laboratories and Academic Institutes

        8.3.4. Others

    8.4. Market  Attractiveness Analysis, by End-user

9. Global Needle Biopsy Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Needle Biopsy Market Value Forecast, by Region

        9.2.1. Europe

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market  Attractiveness Analysis, by Region

10. North America   Needle Biopsy Market Analysis and Forecast

    10.1.  Introduction

        10.1.1.  Key Findings

    10.2.  North America Needle Biopsy Market Value  & Volume Forecast, by Type, 2018–2030

        10.2.1. Fine-Needle Aspiration Biopsy

        10.2.2. Core Needle Biopsy

    10.3. North America Needle Biopsy Market Value Forecast, by Application, 2018–2030

        10.3.1. Breast Cancer

        10.3.2. Thyroid Cancer

        10.3.3. Prostate Cancer

            10.3.3.1. Transperineal

            10.3.3.2. Transrectal

        10.3.4. Liver Cancer

        10.3.5. Others

    10.4. North America Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        10.4.1. Hospitals

        10.4.2. Diagnostics and Imaging Centers

        10.4.3. Research Laboratories and Academic Institutes

        10.4.4. Others

    10.5. North America Needle Biopsy Market Value Forecast, by Country, 2018–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Needle Biopsy Market Attractiveness Analysis

        10.6.1. By Type   

        10.6.2. By Application   

        10.6.3. By End-user  

        10.6.4. By Country

11. Europe Needle Biopsy Market Analysis and Forecast

    11.1.  Introduction

        11.1.1.  Key Findings

    11.2.  Europe Needle Biopsy Market Value  & Volume Forecast, by Type, 2018–2030

        11.2.1. Fine-Needle Aspiration Biopsy

        11.2.2. Core Needle Biopsy

    11.3. Europe Needle Biopsy Market Value & Volume Forecast, by Application, 2018–2030

        11.3.1. Breast Cancer

        11.3.2. Thyroid Cancer

        11.3.3. Prostate Cancer

            11.3.3.1. Transperineal

            11.3.3.2. Transrectal

        11.3.4. Liver Cancer

        11.3.5. Others

    11.4. Europe Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        11.4.1. Hospitals

        11.4.2. Diagnostics and Imaging Centers

        11.4.3. Research Laboratories and Academic Institutes

        11.4.4. Others

    11.5. Europe Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Needle Biopsy Market Attractiveness Analysis

        11.6.1. By Type   

        11.6.2. By Application   

        11.6.3. By End-user  

        11.6.4. By Country/Sub-region

12. Asia Pacific Needle Biopsy Market Analysis and Forecast

    12.1.  Introduction

        12.1.1.  Key Findings

    12.2.  Asia Pacific Needle Biopsy Market Value  & Volume Forecast, by Type, 2018–2030

        12.2.1. Fine-Needle Aspiration Biopsy

        12.2.2. Core Needle Biopsy

    12.3. Asia Pacific Needle Biopsy Market Value Forecast, by Application, 2018–2030

        12.3.1. Breast Cancer

        12.3.2. Thyroid Cancer

        12.3.3. Prostate Cancer

            12.3.3.1. Transperineal

            12.3.3.2. Transrectal

        12.3.4. Liver Cancer

        12.3.5. Others

    12.4. Asia Pacific Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        12.4.1. Hospitals

        12.4.2. Diagnostics and Imaging Centers

        12.4.3. Research Laboratories and Academic Institutes

        12.4.4. Others

    12.5. Asia Pacific Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030

        12.5.1. China

        12.5.2. India

        12.5.3. Japan

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Needle Biopsy Market Attractiveness Analysis

        12.6.1. By Type   

        12.6.2. By Application   

        12.6.3. By End-user  

        12.6.4. By Country/Sub-region

13. Latin America Needle Biopsy Market Analysis and Forecast

    13.1.  Introduction

        13.1.1.  Key Findings

    13.2.  Latin America Needle Biopsy Market Value  & Volume Forecast, by Type, 2018–2030

        13.2.1. Fine-Needle Aspiration Biopsy

        13.2.2. Core Needle Biopsy

    13.3. Latin America Needle Biopsy Market Value Forecast, by Application, 2018–2030

        13.3.1. Breast Cancer

        13.3.2. Thyroid Cancer

        13.3.3. Prostate Cancer

            13.3.3.1. Transperineal

            13.3.3.2. Transrectal

        13.3.4. Liver Cancer

        13.3.5. Others

    13.4. Latin America Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        13.4.1. Hospitals

        13.4.2. Diagnostics and Imaging Centers

        13.4.3. Research Laboratories and Academic Institutes

        13.4.4. Others

    13.5. Latin America Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Needle Biopsy Market Attractiveness Analysis

        13.6.1. By Type   

        13.6.2. By Application   

        13.6.3. By End-user  

        13.6.4. By Country/Sub-region

14. Middle East & Africa Needle Biopsy Market Analysis and Forecast

    14.1.  Introduction

        14.1.1.  Key Findings

    14.2.  Middle East & Africa Needle Biopsy Market Value  & Volume Forecast, by Type, 2018–2030

        14.2.1. Fine-Needle Aspiration Biopsy

        14.2.2. Core Needle Biopsy

    14.3. Middle East & Africa Needle Biopsy Market Value Forecast, by Application, 2018–2030

        14.3.1. Breast Cancer

        14.3.2. Thyroid Cancer

        14.3.3. Prostate Cancer

            14.3.3.1. Transperineal

            14.3.3.2. Transrectal

        14.3.4. Liver Cancer

        14.3.5. Others

    14.4. Middle East & Africa Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        14.4.1. Hospitals

        14.4.2. Diagnostics and Imaging Centers

        14.4.3. Research Laboratories and Academic Institutes

        14.4.4. Others

    14.5. Middle East & Africa Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Needle Biopsy Market Attractiveness Analysis

        14.6.1. By Type   

        14.6.2. By Application   

        14.6.3. By End-user  

        14.6.4. By Country/Sub-region

15. Competitive Landscape

    15.1. Market  Player – Competition Matrix (By Tier and Size of companies)

    15.2. Company Share Analysis

    15.3.  Company Profiles

        15.3.1. Hologic, Inc.

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Financial Overview

            15.3.1.3. Product Portfolio

            15.3.1.4. Strategic Overview

            15.3.1.5. SWOT Analysis

        15.3.2. C. R. Bard, Inc. (Becton, Dickinson and Company).

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Financial Overview

            15.3.2.3. Product Portfolio

            15.3.2.4. Strategic Overview

            15.3.2.5. SWOT Analysis

        15.3.3.  INRAD, Inc.

            15.3.3.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Financial Overview

            15.3.3.3. Product Portfolio

            15.3.3.4. Strategic Overview

            15.3.3.5. SWOT Analysis

        15.3.4.  Argon Medical

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Financial Overview

            15.3.4.3. Product Portfolio

            15.3.4.4. Strategic Overview

            15.3.4.5. SWOT Analysis

        15.3.5. CONMED Corporation

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Financial Overview

            15.3.5.3. Product Portfolio

            15.3.5.4. Strategic Overview

            15.3.5.5. SWOT Analysis

        15.3.6. Olympus Corporation

            15.3.6.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Financial Overview

            15.3.6.3. Product Portfolio

            15.3.6.4. Strategic Overview

            15.3.6.5. SWOT Analysis

        15.3.7. Stryker Corporation

            15.3.7.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Financial Overview

            15.3.7.3. Product Portfolio

            15.3.7.4. Strategic Overview

            15.3.7.5. SWOT Analysis

        15.3.8.  Medtronic plc

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Financial Overview

            15.3.8.3. Product Portfolio

            15.3.8.4. Strategic Overview

            15.3.8.5. SWOT Analysis

        15.3.9. Merit Medical Systems, Inc.

            15.3.9.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Financial Overview

            15.3.9.3. Product Portfolio

            15.3.9.4. Strategic Overview

            15.3.9.5. SWOT Analysis